Quinupristin-dalfopristin

Quinupristin-dalfopristin Structure
CAS No.
126602-89-9
Chemical Name:
Quinupristin-dalfopristin
Synonyms
SYNERCID;Quinupristin-dalfopristin;Mixture with quinupristin;Quinupristin-Dalfopristin complex;Quinupristin dalfopristin mesylate;Quinipristine+ Dalfopristin Mesylate;Mepanipyrim Impurity 2-d5 (Cyprodinil-d5);Quinupristin-Dalfopristin Mesylate coMplex;Synercid coMplex, Dalfopristin-Quinupristin coMplex;Quinupristin-dalfopristin Mesylate complex DISCONTINUED
CBNumber:
CB11252296
Molecular Formula:
C87H117N13O19S2
Molecular Weight:
1713.09
MOL File:
126602-89-9.mol
Modify Date:
2023/5/17 10:26:09

Quinupristin-dalfopristin Properties

InChIKey PPKJUHVNTMYXOD-JAPDWZECNA-N

Quinupristin-dalfopristin Chemical Properties,Uses,Production

Description

Dalfopristin and Quinupristin are two well-defined semi-synthetic antibacterials belonging to the class of streptogramins. Together, they form Synercid, an injectable formulation in a ratio 70 : 30 that was launched in the UK followed by the US. The two distinct antibiotic agents, pristinamycins, are bacteriostatic in their own right but, when they are in association, act synergistically at the ribosomal level to inhibit protein synthesis. Synercid is the first antibiotic in its class to reach the market. It appears to be a sound treatment alternative for patients with severe or life-threatening infections, such as the most problematic forms of gram-positive nosocomial sepsis including vancomycin-resistant Enterococcus faecium (VREF) or methicillinresistant Staphylococcus aureus (MRSA).

Uses

Quinupristin-dalfopristin mesylate complex is a 70:30 (w/w) complex of two semi-synthetic analogues marketed as SynercidTM. Dalfopristin is a semisynthetic analogue of virginiamycin M, while quinupristin is a semi-synthetic analogue of virginiamycin B. To optimise stability, the compounds are presented as the mesylate salts with 10% sodium mesylate excess to provide a buffered aqueous solution. The complex is more hydrophobic than the naturally-occurring virginiamycin complex, with a readily ionisable group for generating a salt for improved solubility. There is little published data on the synthesis and biological activity of individual components of the complex, however the combination is a highly effective antibiotic, including activity against resistant strains.

Quinupristin-dalfopristin Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 26)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6257 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6739 58 Inquiry
BOC Sciences +1-631-485-4226 United States 19552 58 Inquiry
Wuhan Topule Biopharmaceutical Co., Ltd +8618327326525 China 8467 58 Inquiry
Aladdin Scientific United States 52924 58 Inquiry
Olix (Shanghai) Pharmaceutical Technology Co., Ltd 17316404525; 17316404525 China 9976 58 Inquiry
Shanghai Easy CDMO Co.,Ltd 021-61734564 13854185395; China 10030 58 Inquiry
Shanghai Saikerui Biotechnology Co. , Ltd. 021-58000709 15900491054 China 9531 58 Inquiry
Shanghai Weiyite Biotechnology Co., Ltd 15317051735 China 9500 58 Inquiry
Biosynth Biological Technology (Suzhou) Co Ltd 51288865780 China 6051 58 Inquiry
Quinupristin-dalfopristin SYNERCID Quinupristin-Dalfopristin Mesylate coMplex Synercid coMplex, Dalfopristin-Quinupristin coMplex Mixture with quinupristin Quinupristin-dalfopristin Mesylate complex DISCONTINUED Quinupristin dalfopristin mesylate Quinipristine+ Dalfopristin Mesylate Quinupristin-Dalfopristin complex Mepanipyrim Impurity 2-d5 (Cyprodinil-d5) Quinupristin-dalfopristin mesylate complex, Antibiotic for Culture Media Use Only 126602-89-9 C53H67N9O10SC34H50N4O9S